Literature DB >> 9581076

Serology and immunoglobulin profile in rheumatoid arthritis.

S Adhya1, G Chakraborty, B Hajra, S Bhattacharya, P K Sikdar, S Sinha, P P Banerjee, E Ghosh, P Chakraborty.   

Abstract

One hundred and twenty cases of clinically diagnosed rheumatoid arthritis, 80 non-rheumatoid cases suffering from various other diseases and 40 healthy individuals were investigated for the presence of rheumatoid factor, quantitation of serum immunoglobulin, demonstration of ANA and LE cell phenomenon. Microlatex agglutination test of serum for rheumatoid factor showed 56.6% positivity in rheumatoid group and 3.7% positivity in non-rheumatoid group. All three serum immunoglobulins (IgG, IgM, IgA) were raised in serum in significant titre in cases of rheumatoid arthritis, whereas only IgA lever was elevated in the group of non-rheumatoid diseases. ANA and LE cell phenomenon were observed in 11.7% and 4.4% cases of rheumatoid arthritis who had severe underlying disease. In non-rheumatoid group, only one of 6 cases of systemic lupus erythematosus showed rheumatoid factor and that too in an insignificant titre (less than 1:20). Synovium and synovial fluid contained plenty of plasma cells and lymphocytes. It has been observed that RF appears first in synovial fluid and it may take several months to a year to attain detectable level in serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581076

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  Effect of circulating immune complexes on the binding of rheumatoid factor to histones.

Authors:  H A Gussin; K L Russo; M Teodorescu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

2.  Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research.

Authors:  Celia Cartagena García; Nathalie Balandraud; Jean Roudier; Pierre Lafforgue; Nathalie Lambert; Jean-Marc Busnel
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.